BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bernstein DI, Cardin RD, Smith GA, Pickard GE, Sollars PJ, Dixon DA, Pasula R, Bravo FJ. The R2 non-neuroinvasive HSV-1 vaccine affords protection from genital HSV-2 infections in a guinea pig model. NPJ Vaccines 2020;5:104. [PMID: 33298966 DOI: 10.1038/s41541-020-00254-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sharma D, Sharma S, Akojwar N, Dondulkar A, Yenorkar N, Pandita D, Prasad SK, Dhobi M. An Insight into Current Treatment Strategies, Their Limitations, and Ongoing Developments in Vaccine Technologies against Herpes Simplex Infections. Vaccines 2023;11:206. [DOI: 10.3390/vaccines11020206] [Reference Citation Analysis]
2 Gompels UA, Bravo FJ, Briggs S, Ameri S, Cardin RD, Bernstein DI. Immunisation Using Novel DNA Vaccine Encoding Virus Membrane Fusion Complex and Chemokine Genes Shows High Protection from HSV-2. Viruses 2022;14. [PMID: 36366414 DOI: 10.3390/v14112317] [Reference Citation Analysis]
3 Stanfield BA, Bravo FJ, Dixon DA, Chouljenko VN, Kousoulas KG, Bernstein DI. Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein G. Vaccine 2022;40:6093-9. [PMID: 36114130 DOI: 10.1016/j.vaccine.2022.09.015] [Reference Citation Analysis]
4 Goswami R, Pavon CG, Miller IG, Berendam SJ, Williams CA, Rosenthal D, Gross M, Phan C, Byrd A, Pollara J, Permar SR, Fouda GG. Prenatal Immunization to Prevent Viral Disease Outcomes During Pregnancy and Early Life. Front Virol 2022;2. [DOI: 10.3389/fviro.2022.849995] [Reference Citation Analysis]
5 Stults AM, Sollars PJ, Heath KD, Sillman SJ, Pickard GE, Smith GA. Bovine Herpesvirus 1 Invasion of Sensory Neurons by Retrograde Axonal Transport Is Dependent on the pUL37 Region 2 Effector. J Virol 2022;:e0148621. [PMID: 35420461 DOI: 10.1128/jvi.01486-21] [Reference Citation Analysis]
6 Oh EJ, Yuk YS, Kim JK. Laboratory investigations of herpes simplex virus-1 and -2 clinical samples in Korea. Osong Public Health Res Perspect 2021;12:385-9. [PMID: 34965687 DOI: 10.24171/j.phrp.2021.0146] [Reference Citation Analysis]
7 Krishnan R, Stuart PM. Developments in Vaccination for Herpes Simplex Virus. Front Microbiol 2021;12:798927. [PMID: 34950127 DOI: 10.3389/fmicb.2021.798927] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
8 Stanfield BA, Kousoulas KG, Fernandez A, Gershburg E. Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses. Viruses 2021;13:1637. [PMID: 34452501 DOI: 10.3390/v13081637] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
9 Wijesinghe VN, Farouk IA, Zabidi NZ, Puniyamurti A, Choo WS, Lal SK. Current vaccine approaches and emerging strategies against herpes simplex virus (HSV). Expert Rev Vaccines 2021;:1-20. [PMID: 34296960 DOI: 10.1080/14760584.2021.1960162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Karagounis TK, Pomeranz MK. Viral Venereal Diseases of the Skin. Am J Clin Dermatol 2021;22:523-40. [PMID: 34008162 DOI: 10.1007/s40257-021-00606-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
11 Madavaraju K, Koganti R, Volety I, Yadavalli T, Shukla D. Herpes Simplex Virus Cell Entry Mechanisms: An Update. Front Cell Infect Microbiol 2020;10:617578. [PMID: 33537244 DOI: 10.3389/fcimb.2020.617578] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]